Tanner M - Search Results

1

Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.

Nupponen NN, Porkka K, Kakkola L, Tanner M, Persson K, Borg A, Isola J, Visakorpi T. Nupponen NN, et al. Among authors: tanner m. Am J Pathol. 1999 Jun;154(6):1777-83. doi: 10.1016/S0002-9440(10)65433-8. Am J Pathol. 1999. PMID: 10362802 Free PMC article.

2

In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP. Visakorpi T, et al. Among authors: tanner m. Nat Genet. 1995 Apr;9(4):401-6. doi: 10.1038/ng0495-401. Nat Genet. 1995. PMID: 7795646

3

Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.

Kuukasjärvi T, Tanner M, Pennanen S, Karhu R, Kallioniemi OP, Isola J. Kuukasjärvi T, et al. Among authors: tanner m. Am J Pathol. 1997 Apr;150(4):1465-71. Am J Pathol. 1997. PMID: 9095001 Free PMC article.

4

Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.

Järvinen TA, Tanner M, Bärlund M, Borg A, Isola J. Järvinen TA, et al. Among authors: tanner m. Genes Chromosomes Cancer. 1999 Oct;26(2):142-50. Genes Chromosomes Cancer. 1999. PMID: 10469452

5

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.

Järvinen TA, Tanner M, Rantanen V, Bärlund M, Borg A, Grénman S, Isola J. Järvinen TA, et al. Among authors: tanner m. Am J Pathol. 2000 Mar;156(3):839-47. doi: 10.1016/s0002-9440(10)64952-8. Am J Pathol. 2000. PMID: 10702400 Free PMC article.

6

MYB oncogene amplification in hereditary BRCA1 breast cancer.

Kauraniemi P, Hedenfalk I, Persson K, Duggan DJ, Tanner M, Johannsson O, Olsson H, Trent JM, Isola J, Borg A. Kauraniemi P, et al. Among authors: tanner m. Cancer Res. 2000 Oct 1;60(19):5323-8. Cancer Res. 2000. PMID: 11034064

7

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.

Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, Isola J. Tanner M, et al. Am J Pathol. 2000 Nov;157(5):1467-72. doi: 10.1016/S0002-9440(10)64785-2. Am J Pathol. 2000. PMID: 11073807 Free PMC article.

8

Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer.

Tanner M, Järvinen P, Isola J. Tanner M, et al. Cancer Res. 2001 Jul 15;61(14):5345-8. Cancer Res. 2001. PMID: 11454672

9

Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours.

Laakso M, Tanner M, Isola J. Laakso M, et al. Among authors: tanner m. J Pathol. 2006 Sep;210(1):3-9. doi: 10.1002/path.2022. J Pathol. 2006. PMID: 16823892

10

Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R, Tanner M, Isola J, Barkardottir RB, Borg A, Kallioniemi OP. Tirkkonen M, et al. Among authors: tanner m. Cancer Res. 1997 Apr 1;57(7):1222-7. Cancer Res. 1997. PMID: 9102202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,704 results

Search Page

Filters